Unfolding the Promise of Translational Targeting in Neurodegenerative Disease

Abisambra, J. F., Jinwal, U. K., Blair, L. J., O’Leary, J. C., Li, Q., Brady, S., et al. (2013). Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation. Journal of Neuroscience, 33(22), 9498–9507. doi:10.1523/JNEUROSCI.5397-12.2013.Tau.CrossRefPubMedCentralPubMed

Alton, E. W. F. W, Boyd, A. C., Cheng, S. H., Cunningham S., Davies, J. C., Gill, D. R., & Griesenbach, U., et al. (2013). A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis. Thorax, 68(11), 1075–1077. doi:10.1136/thoraxjnl-2013-203309. http://www.ncbi.nlm.nih.gov/pubmed/23525080.

Alzheimer Association. (2014). Alzheimer’s disease facts and figures.

Auluck, P. K., Chan, H. Y. E., & Trojanowski, J. Q. (2002). Chaperone suppression of {alpha}-synuclein toxicity in a drosophila model for Parkinson’s disease. Science, 295(5556), 865–868.

Auluck, P. K., Meulener, M. C., & Bonini, N. M. (2005). Mechanisms of suppression of {alpha}-synuclein neurotoxicity by Geldanamycin in Drosophila. The Journal of Biological Chemistry, 280(4), 2873–78. doi:10.1074/jbc.M412106200. http://www.ncbi.nlm.nih.gov/pubmed/15556931.

Back, S. H., Schröder, M., Lee, K. Zhang, K. & Kaufman, R. J. (2005). ER stress signaling by regulated splicing: IRE1/HAC1/XBP1. Methods (San Diego, Calif.), 35(4), 395–416. doi:10.1016/j.ymeth.2005.03.001. http://www.ncbi.nlm.nih.gov/pubmed/15804613.

Bellucci, A., Navarria, L., Zaltieri, M., Falarti, E., Bodei, S., Sigala, S., Battistin, L., Spillantini, M., Missale, C. & Spano, P. (2011). Induction of the unfolded protein response by Α-synuclein in experimental models of Parkinson’s Disease. Journal of Neurochemistry, 116(4), 588–605. doi:10.1111/j.1471-4159.2010.07143.x. http://www.ncbi.nlm.nih.gov/pubmed/21166675.

Bernales, S., Soto, M. M. & McCullagh, E. (2012). Unfolded protein stress in the endoplasmic reticulum and mitochondria: A role in neurodegeneration. Frontiers in Aging Neuroscience, 4, 5. doi:10.3389/fnagi.2012.00005. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3336107&tool=pmcentrez&rendertype=abstract.

Brewer, J. W., & Diehl, J. A. (2000). PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proceedings of the National Academy of Sciences of the United States of America, 97(23), 12625–12630. doi:10.1073/pnas.220247197. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18814&tool=pmcentrez&rendertype=abstract.

Brown, M. K., & Naidoo, N. (2012). The endoplasmic reticulum stress response in aging and age-related diseases. Frontiers in Physiology 3, 263. doi:10.3389/fphys.2012.00263. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3429039&tool=pmcentrez&rendertype=abstract.

Brundin, P., Melki, R., & Kopito, R. (2010). Prion-like transmission of protein aggregates in neurodegenerative diseases. Nature Reviews. Molecular Cell Biology 11. Nature Publishing Group: 301–7. http://dx.doi.org/10.1038/nrm2873.

Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M. & Stefani, M. (2002). Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature, 416(6880), 507–511. doi:10.1038/416507a. http://www.ncbi.nlm.nih.gov/pubmed/11932737.

Clarke, R., Cook, K. L., Hu, R., Facey, C. O. B., Tavassoly, I., Schwartz, J. L., & Baumann, W. T. et al. (2012). Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate. Cancer Research, 72(6), 1321–1331. doi:10.1158/0008-5472.CAN-11-3213. http://www.ncbi.nlm.nih.gov/pubmed/22422988.

Connor, T. O., Doherty-Sadleir, K. R., Maus, E., Velliquette, R. A., Cole, S. L., Eimer, W. A., & Hitt, B. et al. (2009). NIH public access 60(6), 988–1009. doi:10.1016/j.neuron.2008.10.047.Phosphorylation.

Costanzo, M., & Zurzolo, C. (2013). The cell biology of prion-like spread of protein aggregates: Mechanisms and implication in neurodegeneration. The Biochemical Journal, 452(1), 1–17. doi:10.1042/BJ20121898. http://www.ncbi.nlm.nih.gov/pubmed/23614720.

Credle, J. J., Finer-Moore, J. S., Papa, F. R., Stroud, R. M. & Walter, P. (2005). On the mechanism of sensing unfolded protein in the endoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America, 102(52), 18773–84. doi:10.1073/pnas.0509487102. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1316886&tool=pmcentrez&rendertype=abstract.

Dimopoulos, M. -A., Mitsiades, C. S., Anderson, K. C., & Richardson P. G. (2011). Tanespimycin as antitumor therapy. Clinical Lymphoma, Myeloma & Leukemia, 11(1). Elsevier Inc. 17–22. doi:10.3816/CLML.2011.n.002. http://www.ncbi.nlm.nih.gov/pubmed/21454186.

Feldman, D. E., Chauhan, V., & Koong, A. C. (2005). The unfolded protein response: A novel component of the hypoxic stress response in tumors. Mol Cancer Res, 3(11), 597–605. doi:10.1158/1541-7786.mcr-05-0221. http://www.ncbi.nlm.nih.gov/pubmed/16317085.

Fernández-Nogales, M., Cabrera, J. R., Santos-Galindo, M., Hoozemans, J. J. M., Ferrer, I., Rozemuller, A. J. M., Hernández, F., Avila, J. & Lucas, J. J. (2014). Huntington’s disease is a four-repeat tauopathy with tau nuclear rods. Nature Medicine, 20(8), 881–85. doi:10.1038/nm.3617. http://www.ncbi.nlm.nih.gov/pubmed/25038828.

Ferretti, M. T., Allard, S., Partridge, V., Ducatenzeiler, A., & Cuello, A. C. (2012). Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer’s disease-like amyloid pathology. Journal of Neuroinflammation, 9(1). BioMed Central Ltd: 62. doi:10.1186/1742-2094-9-62. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3352127&tool=pmcentrez&rendertype=abstract.

Gardner, B. M., & Walter, P. (2011). Unfolded proteins are Ire1-activating ligands that directly induce the unfolded protein response. Science (New York, N.Y.), 333(6051), 1891–1894. doi:10.1126/science.1209126. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3202989&tool=pmcentrez&rendertype=abstract.

Gorbatyuk, M. S., Shabashvili, A., Chen, W., Meyers, C., Sullivan, L. F., Salganik, M., Lin, J. H., Lewin, A. S., Muzyczka, N., & Gorbatyuk, O. S. (2012). Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease. Molecular Therapy: The Journal of the American Society of Gene Therapy, 20(7). Nature Publishing Group: 1327–1337. doi:10.1038/mt.2012.28. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3392977&tool=pmcentrez&rendertype=abstract.

Halliday, M., & Mallucci, G. R. (2014). Targeting the unfolded protein response in neurodegeneration: A new approach to therapy. Neuropharmacology, 76 Pt A. Elsevier: 169–174. doi:10.1016/j.neuropharm.2013.08.034. http://www.ncbi.nlm.nih.gov/pubmed/24035917.

Harding, H. P., Zhang, Y., Bertolotti, A., Zeng, H., & Ron, D. (2000). Perk is essential for translational regulation and cell survival during the unfolded protein response. Molecular Cell, 5(5): 897–904. http://www.ncbi.nlm.nih.gov/pubmed/10882126.

Höglinger, G. U., Melhem, N. M., Dickson, D. W., Sleiman, P. M. A., Wang, L. -S., Klei, L., & Rademakers, R. et al. (2011). Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nature Genetics, 43(7). Nature Publishing Group: 699–705. doi:10.1038/ng.859. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3125476&tool=pmcentrez&rendertype=abstract.

Holsinger, D. R. M, McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002). Increased expression of the amyloid precursor B-secretase in Alzheimer’s disease. Annals of Neurology, 51(6), 782–786. doi:10.1002/ana.10168. http://www.ncbi.nlm.nih.gov/pubmed/12112082.

Investigators, MADE. (2013). Minocycline in Alzheimer’ S disease efficacy trial: The MADE trial. NIHR Protocol, 1–32.

Investigators, Ninds Net-Pd. (2006). A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology, 66(5). AAN Enterprises: 664–671.

Kakimura, J., Kitamura, Y., Taniguchi, T., Shimohama, S., & Gebicke-Haerter, P. J. (2001). Bip/GRP78-induced production of cytokines and uptake of amyloid-beta(1-42) peptide in microglia. Biochemical and Biophysical Research Communications, 281(1), 6–10. doi:10.1006/bbrc.2001.4299. http://www.ncbi.nlm.nih.gov/pubmed/11178952.

Korennykh, A. V., Egea, P. F., Korostelev, A. A., Finer-moore, J., Shokat, K. M., Stroud, R. M. & Walter, P. (2010). NIH public access, 457(3), 687–693. doi:10.1038/nature07661.The.

Kosmaczewski, S. G., Edwards, T. J., Han, S. M., Eckwahl, M. J., Meyer, B. I., Peach, S., Hesselberth, J. R., Wolin, S. L., & Hammarlund, M. (2014). The RtcB RNA ligase is an essential component of the metazoan unfolded protein response. EMBO Reports, 15(12), 1278–1285. doi:10.15252/embr.201439531. http://www.ncbi.nlm.nih.gov/pubmed/25366321.

Kudo, T, Kanemoto, S., Hara, H., Morimoto, N., Morihara, T., Kimura, R., Tabira, T., Imaizumi, K., & Takeda, M. (2008). A molecular chaperone inducer protects neurons from ER stress. Cell Death and Differentiation, 15(2), 364–375. doi:10.1038/sj.cdd.4402276. http://www.ncbi.nlm.nih.gov/pubmed/18049481.

Lee, A. S. (2007). GRP78 induction in cancer: Therapeutic and prognostic implications. Cancer Research, 67(8), 3496–3499. doi:10.1158/0008-5472.CAN-07-0325. http://www.ncbi.nlm.nih.gov/pubmed/17440054.

Lee, J. H., Won, S. M., Suh, J., Son, S. J., Moon, G. J., Park, U. J., & Gwag, B. J. (2010). Induction of the unfolded protein response and cell death pathway in Alzheimer’s disease, but not in aged Tg2576 mice. Experimental & Molecular Medicine, 42(5), 386–94. doi:10.3858/emm.2010.42.5.040. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2877248&tool=pmcentrez&rendertype=abstract.

Lee, E. -J., Woo, M. -S., Moon, P. -G., Baek, M. -C., Choi, I. -Y., Kim, W. -K., Junn, E., & Kim, H. -S. (2010). Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1. Journal of Immunology (Baltimore, Md.: 1950), 185(1), 615–623. doi:10.4049/jimmunol.0903480. http://www.ncbi.nlm.nih.gov/pubmed/20511551.

Li, J., & Lee, A. S. (2006). Stress induction of GRP78/BiP and its role in cancer. Current Molecular Medicine, 6(1), 45–54. http://www.ncbi.nlm.nih.gov/pubmed/16472112.

Loewen, C. A., & Feany, M. B. (2010). The unfolded protein response protects from tau neurotoxicity in vivo. PloS One, 5(9), 1–6. doi:10.1371/journal.pone.0013084. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2947516&tool=pmcentrez&rendertype=abstract.

Luk, K. C., Kehm, V., Carroll, J., Zhang, B., Brien, P. O., Trojanowski, J. Q., & Lee, V. M. (2012). Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science, 338, 949–954.CrossRefPubMedCentralPubMed

Luo, W., Dou, F., Rodina, A., Chip, S., Kim, J., Zhao, Q., & Moulick, K., et al. (2007). Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies. Proceedings of the National Academy of Sciences of the United States of America, 104(22): 9511–9516. doi:10.1073/pnas.0701055104. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1890525&tool=pmcentrez&rendertype=abstract.

Luo, W., Rodina, A., & Chiosis, G. (2008). Heat shock protein 90: translation from cancer to Alzheimer’s disease treatment? BMC Neuroscience, 9(Suppl 2), S7. doi:10.1186/1471-2202-9-S2-S7. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2604891&tool=pmcentrez&rendertype=abstract.

McLaughlin, M., & Vandenbroeck, K. (2011). The endoplasmic reticulum protein folding factory and its chaperones: New targets for drug discovery? British Journal of Pharmacology, 162(2), 328–345. doi:10.1111/j.1476-5381.2010.01064.x. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3031055&tool=pmcentrez&rendertype=abstract.

Moreno, J. A., Radford, H., Peretti, D., Steinert, J. R., Verity, N., Martin, M. G., Halliday, M., et al. (2012). Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature, 485(7399). Nature Publishing Group: 507–511. doi:10.1038/nature11058. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3378208&tool=pmcentrez&rendertype=abstract.

Morimoto, N., Oida, Y., Shimazawa, M., Miura, M., Kudo, T., Imaizumi, K., & Hara, H. (2007). Involvement of endoplasmic reticulum stress after middle cerebral artery occlusion in mice. Neuroscience, 147(4). IBRO: 957–967. doi:10.1016/j.neuroscience.2007.04.017. http://www.ncbi.nlm.nih.gov/pubmed/17590517.

Nakagawa, T., Zhu, H., Morishima, N., & Li, E. (2000). Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. 403, 8–13.

Natale, G., Pompili, E., Biagioni, F., Paparelli, S., Lenzi, P., & Fornai, F. (2013). Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases. European Journal of Histochemistry: EJH, 57(1), e5. doi:10.4081/ejh.2013.e5. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3683612&tool=pmcentrez&rendertype=abstract.

Nijholt, D. A. T., de Graaf, T. R., van Haastert, E. S., Osório Oliveira, A., Berkers, C. R., Zwart, R., Ovaa, H., Baas, F., Hoozemans, J. J. M., & Scheper, W. (2011). Endoplasmic reticulum stress activates autophagy but not the proteasome in neuronal cells: Implications for Alzheimer’s disease. Cell Death and Differentiation, 18(6), 1071–1081. doi:10.1038/cdd.2010.176. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3131935&tool=pmcentrez&rendertype=abstract.

Nunziante, M., Ackermann, K., Dietrich, K., Wolf, H., Gädtke, L., Gilch, S., Vorberg, I., Groschup, M., & Schätzl, H. M. (2011). Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein. The Journal of Biological Chemistry, 286(39). 9650 Rockville Pike, Bethesda, MD 20814, U.S.A.: American Society for Biochemistry and Molecular Biology: 33942–33953. doi:10.1074/jbc.M111.272617. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190803/.

Ochel, H. -J., Eichhorn, K., & Gademann, G. (2001). Geldanamycin: The prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones. Cell Stress & Chaperones, 6(2), 105. doi:10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2. http://cest.allenpress.com/perlserv/?request=get-abstract&doi=10.1379%2F1466-1268(2001)006%3C0105%3AGTPOAC%3E2.0.CO%3B2.

Okada, T., Yoshida, H., Akazawa, R., Negishi, M., & Mori, K. (2002). Distinct roles of activating transcription factor 6 (ATF6) and double-stranded RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) in transcription during the mammalian unfolded protein response. The Biochemical Journal, 366(Pt 2), 585–594. doi:10.1042/BJ20020391. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1222788&tool=pmcentrez&rendertype=abstract.

Peng, J., Liang, G., Inan, S., Joseph, D. J., Meng, Q., Peng, Y., et al. (2012). Dantrolene ameliorates cognitive decline and neuropathology in alzheimer triple transgenic mice. Neuroscience Letters, 516(2), 274–279. doi:10.1016/j.neulet.2012.04.008.Dantrolene.CrossRefPubMedCentralPubMed

Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013). The global prevalence of dementia: A systematic review and metaanalysis. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 9(1). Elsevier Ltd: 63–75.e2. doi:10.1016/j.jalz.2012.11.007. http://www.ncbi.nlm.nih.gov/pubmed/23305823.

Quinones, Q. J., de Ridder, G. G., & Pizzo, S. V. (2008). GRP78: A chaperone with diverse roles beyond the endoplasmic reticulum. Histology and Histopathology, 23(11), 1409–1416. http://www.ncbi.nlm.nih.gov/pubmed/18785123.

Reddy, R. K, Mao, C., Baumeister, P., Austin, R. C., Kaufman, R. J., & Lee, A. S. (2003). Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: Role of ATP binding site in suppression of caspase-7 activation. The Journal of Biological Chemistry, 278(23), 20915–20924. doi:10.1074/jbc.M212328200. http://www.ncbi.nlm.nih.gov/pubmed/12665508.

Rissanen, A., Sivenius, J., & Jolkkonen, J. (2006). Prolonged bihemispheric alterations in unfolded protein response related gene expression after experimental stroke. Brain Research, 1087(1), 60–66. doi:10.1016/j.brainres.2006.02.095. http://www.ncbi.nlm.nih.gov/pubmed/16684512.

Roussel, B. D., Kruppa, A. J., Miranda, E., Crowther, D. C., Lomas, D. A., & Marciniak, S. J. (2013) Endoplasmic reticulum dysfunction in neurological disease. The Lancet Neurology, 12(1). Elsevier Ltd: 105–118. doi:10.1016/S1474-4422(12)70238-7. http://www.ncbi.nlm.nih.gov/pubmed/23237905.

Sano, M., Thomas, R. G., & Van Dyck, C. H. (2011). Placebo-controlled trial of simvastatin to treat Alzheimer sisease.

Scheper, W., Nijholt, D. A. T., & Hoozemans, J. J. M. (2011). The unfolded protein response and proteostasis in Alzheimer disease: Preferential activation of autophagy by endoplasmic reticulum stress. Autophagy, 7(8), 910–911. doi:10.4161/auto.7.8.15761. http://www.landesbioscience.com/journals/autophagy/article/15761/.

Schröder, M., & Kaufman, R. J. (2005a). The mammalian unfolded protein response. Annual Review of Biochemistry, 74, 739–789. doi:10.1146/annurev.biochem.73.011303.074134. http://www.ncbi.nlm.nih.gov/pubmed/15952902.

Schröder, M., & Kaufman, R. J. (2005b). ER stress and the unfolded protein response. Mutation Research, 569(1–2), 29–63. doi:10.1016/j.mrfmmm.2004.06.056. http://www.ncbi.nlm.nih.gov/pubmed/15603751.

Stutzbach, L. D., Xie, S. X., Naj, A. C., Albin, R., Gilman, S., Lee, V. M. Y., Trojanowski, J. Q., Devlin, B., & Schellenberg, G. D. (2013). The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear Palsy and Alzheimer’s disease. Acta Neuropathologica Communications, 1(1), 31. doi:10.1186/2051-5960-1-31. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3893579&tool=pmcentrez&rendertype=abstract.

Szegezdi, E., Logue, S. E., Gorman, A. M., & Samali, A. (2006). Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Reports, 7(9), 880–885. doi:10.1038/sj.embor.7400779. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1559676&tool=pmcentrez&rendertype=abstract.

Thakur, P., & Nehru, B. (2014). Long-term heat shock proteins (HSPs) induction by carbenoxolone improves hallmark features of Parkinson’s disease in a rotenone-based model. Neuropharmacology, 79. Elsevier Ltd: 190–200. doi:10.1016/j.neuropharm.2013.11.016. http://www.ncbi.nlm.nih.gov/pubmed/24296154.

Tirasophon, W., Welihinda, A. A., & Kaufman, R. J. (1998). A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/endoribonuclease (Ire1p) in mammalian cells. Genes & Development, 12(12), 1812–1824. doi:10.1101/gad.12.12.1812. http://www.genesdev.org/cgi/doi/10.1101/gad.12.12.1812.

Ulloa-Aguirre, A., & Conn, P. M. (2012). Pharmacoperones: A new therapeutic approach for diseases caused by misfolded G protein-coupled receptors. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 5(1), 13–24.CrossRef

Urban, P., Pavlíková, M., Sivonová, M., Kaplán, P., Tatarková, Z., Kaminska, B., & Lehotský, J. (2009). Molecular analysis of endoplasmic reticulum stress response after global forebrain ischemia/reperfusion in rats: Effect of neuroprotectant simvastatin. Cellular and Molecular Neurobiology 29 (2): 181–92. doi:10.1007/s10571-008-9309-7. http://www.ncbi.nlm.nih.gov/pubmed/18807172.

Valdés, P., Mercado, G., Vidal, R. L., Molina, C., Parsons, G., Court, F. A., Martinez, A., et al. (2014). Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. Proceedings of the National Academy of Sciences of the United States of America, 111(18), 6804–6809. doi:10.1073/pnas.1321845111. http://www.ncbi.nlm.nih.gov/pubmed/24753614.

Valera, E., Dargusch, R., Maher, P. A., & Schubert, D. (2013). Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer’s disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 33(25), 10512–10525. doi:10.1523/JNEUROSCI.5183-12.2013. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3685841&tool=pmcentrez&rendertype=abstract.

Van der Harg, J. M., Nölle, A., Zwart, R., Boerema, A. S., van Haastert, E. S., Strijkstra, A. M., Hoozemans, J. J., & Scheper, W. (2014). The unfolded protein response mediates reversible tau phosphorylation induced by metabolic stress. Cell Death & Disease, 5, e1393. doi:10.1038/cddis.2014.354. http://www.ncbi.nlm.nih.gov/pubmed/25165879.

Vaughn, L. S., Snee, B., & Patel, R. C. (2014). Inhibition of PKR protects against tunicamycin-induced apoptosis in neuroblastoma cells. Gene, 536(1). Elsevier B.V. 90–96. doi:10.1016/j.gene.2013.11.074. http://www.ncbi.nlm.nih.gov/pubmed/24334130.

Yan, Y. (2013). Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder, 1089–1095.

Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., & Mori, K. (2001). XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell, 107(7), 881–891. http://www.ncbi.nlm.nih.gov/pubmed/11779464.

Zhang, C., & Bazan, N. G. (2010). Lipid-mediated cell signaling protects against. doi:10.3945/jn.109.114884.858.

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Unfolding the Promise of Translational Targeting in Neurodegenerative Disease

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2015

A Candidate Gene Association Study Identifies DAPL1 as a Female-Specific Susceptibility Locus for Age-Related Macular Degeneration (AMD)

A Dual Inhibitor of Cyclooxygenase and 5-Lipoxygenase Protects Against Kainic Acid-Induced Brain Injury

TSC1 R509X Mutation in a Chinese Family with Tuberous Sclerosis Complex

Erratum to: Genetic Association Between KIBRA Polymorphism and Alzheimer’s Disease with in a Japanese Population

Circulating MicroRNA Let-7d in Attention-Deficit/Hyperactivity Disorder

Epigenetics of Multiple Sclerosis: An Updated Review